News Releases
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2021 Results
– Announced growth-oriented and accretive transactions of up to $186 million – – Continued strong performance of existing assets and financial results – – Acquired over one million units under…
DRI Healthcare Trust Comments on FDA Approval of VONJOTM (pacritinib)
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI”) today announced that it has been notified by CTI BioPharma Corp. (“CTI”) that the U.S. Food and Drug Administration (“FDA”) has approved…
DRI Healthcare Trust to Host Fourth Quarter Earnings Call and Webcast on March 8, 2022
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its fourth quarter and full-year 2021 financial results on Tuesday,…
DRI Healthcare Trust Declares Special Distributions
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that its Board of Trustees has declared a special cash distribution in the amount of US$0.22 per trust unit….
DRI Healthcare Trust Comments on Extension of Review Period for pacritinib
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that it has been notified by CTI BioPharma Corp. (CTI) that the U.S. Food and Drug Administration (FDA) has…
DRI Healthcare Trust Reports Third Quarter 2021 Results and Announces Increase to Quarterly Distribution
– Continued strong performance of core royalty assets – – Demonstrated growth strategy execution through two transactions valued at up to $185 million – – Quarterly distribution doubled to…
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 9, 2021
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its 2021 third quarter financial results on Tuesday, November 9,…
DRI Healthcare Trust Announces US$200 Million Credit Facility
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that a subsidiary of the Trust has entered into a credit agreement with a syndicate of banks regarding US$200…
DRI Healthcare Trust Announces Acceptance by TSX of Normal Course Issuer Bid
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today the acceptance by the Toronto Stock Exchange (the “TSX”) of the Trust’s Notice of Intention to make a normal…
DRI Healthcare Trust Announces Acquisition of Royalty on Oracea®
– Oracea® is the only branded oral prescription medication indicated for papulopustular rosacea – TORONTO, Sept. 30, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”
